9987.T Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 09:15):

Stats
Объем за сегодня	829 300
Средний объем	280 838
Рыночная капитализация	280.71B
EPS	¥0 ( 2024-02-08 )
Дата следующего отчета о доходах	( ¥83.23 ) 2024-05-13
Last Dividend	¥36.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	13.77
ATR14	¥4.77 (0.10%)

Объем Корреляция

Длинно: 0.31 (neutral)

Кратко: 0.00 (neutral)

Signal:(52.709) Neutral

Suzuken Co., Ltd. Корреляция

10 Самые положительные корреляции

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Suzuken Co., Ltd. Корреляция - Валюта/Сырье

0.78
( moderate )

0.79
( moderate )

0.42
( neutral )

0.75
( moderate )

-0.20
( neutral )

-0.06
( neutral )

Suzuken Co., Ltd. Финансовые показатели

Annual	2022
Выручка:	¥2 314.83B
Валовая прибыль:	¥179.70B (7.76 %)
EPS:	¥236.46

FY	2022
Выручка:	¥2 314.83B
Валовая прибыль:	¥179.70B (7.76 %)
EPS:	¥236.46

FY	2022
Выручка:	¥2 232.77B
Валовая прибыль:	¥160.99B (7.21 %)
EPS:	¥163.19

FY	2021
Выручка:	¥2 128.48B
Валовая прибыль:	¥157.84B (7.42 %)
EPS:	¥88.52

Financial Reports:

No articles found.

Suzuken Co., Ltd. Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥36.00 (N/A)	¥0 (N/A)	¥36.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Suzuken Co., Ltd. Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 6.61 - average (87.08%) | Divividend Growth Potential Score: 2.58 - Decrease likely (48.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥9.09	2001-03-27
Last Dividend	¥36.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	46	--
Total Paid Out	¥939.27	--
Avg. Dividend % Per Year	0.00%	--
Score	2.84	--
Div. Sustainability Score	6.61
Div.Growth Potential Score	2.58
Div. Directional Score	4.59	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.26 %

Dividend Stability

0.10 Bad

Dividend Score

2.84

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8331.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
7717.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%
6871.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
6245.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4967.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
4172.T	Ex Dividend Junior	2023-09-28	Annually	0.00%
3355.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
2429.T	Ex Dividend Junior	2023-12-28	Annually	0.00%
9368.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8058.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0117	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0212	1.200	9.29	10.00	[0 - 0.3]
returnOnEquityTTM	0.0664	1.500	-0.373	-0.560	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.186	0.800	9.07	7.26	[1 - 3]
quickRatioTTM	0.954	0.800	9.10	7.28	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	807.19	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.0775	1.000	-2.04	-2.04	[0.2 - 0.8]
operatingProfitMarginTTM	0.0146	1.000	-1.707	-1.707	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.818	0.800	1.213	0.970	[0.5 - 2]
Total Score				6.61

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.63	1.000	8.72	0	[1 - 100]
returnOnEquityTTM	0.0664	2.50	-0.240	-0.560	[0.1 - 1.5]
freeCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	1.718	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	212.65	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-3.53	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.00727	1.000	-2.32	0	[0.1 - 0.5]
Total Score				2.58

Suzuken Co., Ltd.

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the wholesale of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution Business, Pharmaceutical Manufacturing Business, Pharmacy Business, and Healthcare-Related Services Business. The Pharmaceutical Distribution Business segment procures ethical drugs, diagnostic reagents, medical equipment and supplies, and other health-related items from manufacturers and supplies to medical institutions and pharmacies. The Pharmaceutical Manufacturing Business segment engages in the research and development, manufacturing, and marketing of ethical pharmaceuticals and diagnostic products focusing on the areas of diabetes and kidney diseases. The Pharmacy Business segment provides services through family pharmacists, as well as improves the operations of local pharmacies and provides educational support. The Healthcare-Related Services Business segment provides manufacturer support services, such as contract distribution for manufacturers; distribution of orphan drugs; and nursing care services, as well as develops, manufactures, and sells electrocardiographs, sphygmomanometers, stethoscopes, medical materials, and health promotion equipment. Suzuken Co., Ltd. also publishes medical magazines for medical institutions. The company has collaboration with Bushu Pharmaceuticals Ltd. provide contract specialty drug services. Suzuken Co., Ltd. was founded in 1932 and is headquartered in Nagoya, Japan.